Biotech

All Articles

Galecto buys leukemia medication, drops bone cancer cells resource in pivot

.A year after the breakdown of an idiopathic lung fibrosis applicant sent out Galecto on a hunt for ...

Judo throws down $100M to knock senseless kidney ailment

.Taking the mat is actually Judo Biography, a promising biotech equipped with $one hundred thousand ...

AstraZeneca spends CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has actually paid CSPC Drug Team $100 thousand for a preclinical heart disease medicine...

Zephyrm finds Hong Kong IPO to cash period 3 tissue treatment trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, declaring (PDF) for an ...

Frazier Lifestyle Sciences gets $630M for tiny, mid-cap biotechs

.Frazier Life Sciences has actually sourced an additionally $630 million for its own fund concentrat...

GigaGen amasses approximately $135M BARDA bucks to beat botulism

.Antitoxin fan GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its tech to take on...

GPCR agency Septerna apply for IPO on strength of preclinical data

.Septerna will figure out how a biotech without "any kind of meaningful clinical records" meals in t...

Kurma finalizes initially $154M haul for largest biotech fund yet

.International VC organization Kurma Partners has revealed its own most current biotech fund, along ...

Prothena promotes one director while an additional leaves behind-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings a...

Editas cashes in on Vertex Cas9 licensing legal rights for $57M

.Against the background of a Cas9 patent fight that refuses to perish, Editas Medication is cashing ...